DTC
GILD icon

Davidson Trust Company’s Gilead Sciences GILD Stock Holding History

Davidson Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Hold
1,879
– – 0.09% 172
2026
Q1 		$262K Buy
1,879
+74
+4% +$10.4K 0.11% 150
2025
Q4 		$222K Sell
1,805
-145
-7% -$17.6K 0.09% 163
2025
Q3 		$216K Buy
+1,950
New +$222K 0.09% 165
2025
Q2 		– Sell
-1,808
Closed -$203K – 162
2025
Q1 		$203K Buy
+1,808
New +$187K 0.1% 161

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Davidson Trust Company's GILD Position: Q2 2026 in Review

Davidson Trust Company held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,879 shares worth $237K. The position accounts for 0.09% of the portfolio, ranked #172.

Davidson Trust Company first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $262K in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Davidson Trust Company held 1,879 shares of Gilead Sciences worth $237K as of Q2 2026.
  • Davidson Trust Company left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.09% of Davidson Trust Company's portfolio in Q2 2026, its #172 holding.
  • Davidson Trust Company first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Davidson Trust Company's Gilead Sciences position peaked at $262K in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Davidson Trust Company's 13F filing for Q2 2026, filed 29 Jul 2026.